Premium
Krystal Biotech Inc (KRYS)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. John C. ThomasEVP, General Counsel & Corporate Secretary | -642,00 | 193,90k | Automatic Disposition | 302,03 | 0,00 | -100,00% |
| 2026-03-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -24,59k | 6,48M | Vente | 258,54 - 266,42 | 1,49M | -1,62% |
| 2026-03-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -407,00 | 104,73k | Automatic Disposition | 257,32 | 1,49M | -0,03% |
| 2026-03-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -483,00 | 124,28k | Automatic Disposition | 257,31 | 1,48M | -0,03% |
| 2026-03-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -24,52k | 6,45M | Vente | 258,38 - 266,56 | 1,48M | -1,63% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | 7,50k | 0,00 | Derivative Exercise and Retained Stock | - | 22,37k | 50,45% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | -550,00 | 149,11k | Derivative Exercise and Sale | 267,60 - 275,64 | 22,37k | - |
| 2026-03-02 | Ms. Kathryn A. RomanoExec. VP & CAO | -440,00 | 117,74k | Automatic Disposition | 267,60 | 22,37k | -1,93% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | -3,26k | 899,14k | Sale to Issuer | 275,64 | 22,37k | -12,73% |
| 2026-02-27 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | 22,20k | 0,00 | Derivative Exercise and Retained Stock | - | 1,59M | 1,42% |
| 2026-02-27 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -18,53k | 5,11M | Derivative Exercise and Sale | 275,64 | 1,59M | - |
| 2026-02-27 | Ms. Suma M. KrishnanFounder, President of R&D and Director | 14,44k | 0,00 | Derivative Exercise and Retained Stock | - | 1,52M | 0,96% |
| 2026-02-27 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -12,06k | 3,32M | Derivative Exercise and Sale | 275,64 | 1,52M | - |
| 2026-02-27 | Alta BioequitiesSociété | -11,80k | 3,25M | Automatic Disposition | 275,45 - 276,17 | 73,29k | -13,87% |
| 2026-02-24 | Mr. Daniel S. JanneyLead Independent Director | -37,90k | 10,02M | Derivative Exercise and Sale | 2,46 - 271,09 | 0,00 | - |
| 2026-02-24 | Alta BioequitiesSociété | -22,27k | 6,04M | Automatic Disposition | 263,05 - 276,32 | 85,10k | -20,74% |
| 2026-02-19 | Mr. Dino A. RossiIndependent Director | -18,95k | 4,79M | Derivative Exercise and Sale | 8,79 - 262,10 | 78,69k | - |
| 2026-02-09 | Ms. Kathryn A. RomanoExec. VP & CAO | -12,50k | 2,61M | Derivative Exercise and Sale | 63,55 - 277,88 | 18,57k | - |
| 2026-02-09 | Ms. Kathryn A. RomanoExec. VP & CAO | -750,00 | 0,00 | Other Disposition | - | 18,57k | -3,88% |
| 2025-12-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -25,00k | 5,50M | Automatic Disposition | 214,28 - 222,20 | 1,57M | -1,57% |
| 2025-12-05 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -5,00k | 0,00 | Other Disposition | - | 1,57M | -0,32% |
| 2025-12-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -25,00k | 5,50M | Automatic Disposition | 214,25 - 222,38 | 1,50M | -1,64% |
| 2025-07-14 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -18,00k | 2,71M | Automatic Disposition | 150,00 - 151,79 | 1,53M | -1,16% |
| 2025-07-14 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -17,87k | 2,69M | Automatic Disposition | 150,00 - 151,79 | 1,51M | -1,17% |
| 2025-07-09 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -7,00k | 1,05M | Automatic Disposition | 150,14 - 151,39 | 1,55M | -0,45% |
| 2025-07-09 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -7,13k | 1,07M | Automatic Disposition | 150,07 - 151,39 | 1,53M | -0,46% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
